Intake & Induction

This news release summarizes a new study which identified the top reasons why some physicians may be reluctant to intervene in addiction. The comprehensive review, pulling 283 studies published on this topic within the last 61 years, showed that “institutional environment” was the reason most frequently reported in these studies.

This article reviews medication for opioid use disorder (MOUD) treatments in the United States from data pulled from the 2022 National Survey on Drug Use and Health.

This NIDA web page includes facts and figures on addressing substance use disorders in the prison population.

This NIDA resource includes talking points written in plain language as a suggested way to communicate concepts of drug use and addiction to adults or teens.

This NIDA web page includes resources to help decrease substance use, address barriers to care, and improve outcomes among people in jail and prison systems.

This two-page pocket guide includes facts and a checklist for all practitioners seeking to prescribe buprenorphine.

This quick start guide includes facts and a checklist for all practitioners seeking to prescribe buprenorphine.

This fact sheet includes several tips for suggesting that a loved one receive treatment for substance use.

This web page provides frequently asked questions regarding the 2023 Consolidated Appropriations Act, which eliminates the X-waiver (DATA-Waiver) and increases accessibility of medication-assisted treatment (MAT).

This letter announces details on Congress's elimination of the X-waiver (DATA-Waiver) to increase buprenorphine accessibility in the Consolidated Appropriations Act of 2023, increasing accessibility of medication-assisted treatment (MAT).